Helios RE Socimi, S.A. (LON:0QRL)
 8.29
 0.00 (0.00%)
  At close: Jan 30, 2025
Helios RE Socimi Revenue
In the year 2024, Helios RE Socimi had annual revenue of 95.20M EUR with 0.30% growth. Helios RE Socimi had revenue of 24.29M in the quarter ending December 31, 2024, with 6.87% growth.
Revenue 
 95.20M EUR
Revenue Growth 
 +0.30%
P/S Ratio 
 7.74
Revenue / Employee 
 23.80M EUR
Employees 
 4
Market Cap 
609.28M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 95.20M | 283.00K | 0.30% | 
| Dec 31, 2023 | 94.92M | 11.36M | 13.59% | 
| Dec 31, 2022 | 83.56M | 4.06M | 5.11% | 
| Dec 31, 2021 | 79.50M | -17.65M | -18.16% | 
| Dec 31, 2020 | 97.15M | 12.27M | 14.46% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |